[1]Mensah G A, Fuster V, Murray C J L, et al. Global burden of cardiovascular diseases and risks, 1990-2022[J]. J Am Coll Cardiol, 2023, 82(25): 2350-2473.
[2]中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志, 2023, 38(6): 583-612.
[3]Attiq A, Afzal S, Ahmad W, et al. Hegemony of inflammation in atherosclerosis and coronary artery disease[J]. Eur J Pharmacol, 2024, 966: 176338.
[4]Hansson G K. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352(16): 1685-1695.
[5]Wei X, Zhang Z, Wei J, et al. Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction[J]. Front Cardiovasc Med, 2023, 10: 1248655.
[6]王亚柱, 郭云飞,薛文平,等. 中性粒细胞与淋巴细胞比值联合脉压对冠心病诊断价值及冠心病发生影响因素分析[J]. 临床误诊误治, 2021, 34 (9): 49-54.
[7]Peng A H, Zhang B, Wang S Y, et al. Comparison of the value of various complex indexes of blood cell types and lipid levels in coronary heart disease[J]. Front Cardiovasc Med, 2023, 10: 1284491.
[8]Liu J, Wei H, Zhu X Z, et al. Contrasting the relationship of serum uric acid/albumin ratio on quantitative flow ratio with other multiple composite parameters in patients with suspected coronary artery disease[J]. BMC Cardiovasc Disord, 2024, 24(1): 146.
[9]Adali M K, Buber I, Sen G, et al. Relação entre o índice imune-inflamação sistêmico e circulação colateral coronariana em pacientes com oclusão total crônica[J]. Arq Bras Cardiol, 2022, 119(1): 69-75.
[10]Mangalesh S, Dudani S, Mahesh N K. Development of a novel inflammatory index to predict coronary artery disease severity in patients with acute coronary syndrome[J]. Angiology, 2024, 75(3): 231-239.
[11]Naser A. The gensini score system is a useful tool in assessing the burden and severity of coronary artery atherosclerotic lesions [letter][J]. Int J Gen Med, 2024, 17: 4227-4228.
[12]Pasqui A L, Bova G, Maffei S, et al. Immune factors in atherosclerosis[J]. Ann Ital Med Int, 2005, 20(2): 81-89.
[13]Josefs T, Barrett T J, Brown E J, et al. Neutrophil extracellular traps promote macrophage inflammation and impair atherosclerosis resolution in diabetic mice[J]. JCI Insight, 2020, 5(7): e134796.
[14]Woollard K J. Immunological aspects of atherosclerosis[J]. Clin Sci, 2013, 125(5): 221-235.
[15]Pinderski Oslund L J, Hedrick C C, Olvera T, et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo[J]. Arterioscler Thromb Vasc Biol, 1999, 19(12): 2847-2853.
[16]Olson N C, Sitlani C M, Doyle M F, et al. Innate and adaptive immune cell subsets as risk factors for coronary heart disease in two population-based cohorts[J]. Atherosclerosis, 2020, 300: 47-53.
[17]Wang H M, Huang Z H, Wang J, et al. Predictive value of system immune-inflammation index for the severity of coronary stenosis in patients with coronary heart disease and diabetes mellitus[J]. Sci Rep, 2024, 14(1): 31370.
|